The effect of anti-CD26 antibodies on DNA synthesis and cytokine production (IL-2, IL-10 and IFN-γ) depends on enzymatic activity of DP IV/CD26

Advances in Experimental Medicine and Biology

Volumn 421, Issue , 1997, Pages 149-155

  Reinhold, D ^a   Kahne T ^a   Tager M ^a   Lendeckel, U ^a   Buhling F ^a   Bank, U ^a   Wrenger, S ^a   Faust, J ^b   Neubert, K ^b   Ansorge, S ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ANALYSIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; T LYMPHOCYTE ACTIVATION;

EID: 9844267958     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9613-1_19     Document Type: Article

References (31)

1. Fleischer, B. (1994) CD26: a surface protease involved in T-cell activation. J. Immunol. 15, 180-184.
2. Morimoto, C. & Schlossman, S. F. (1994) A key costimulatory molecule on CD4 memory T cells. The Immunologist 2, 4-7.
3. Bühling, F., Junker, U., Reinhold, D., Neubert, K., Jäger, L. & Ansorge, S. (1995) Functional role of CD26 on human B lymphocytes. Immunol. Lett. 45, 47-51.
4. Bühling, F., Kunz, D., Reinhold, D., Ulmer, A. J., Ernst, M., Flad, H.-D. & Ansorge, S. (1994) Expression and functional role of dipeptidyl peptidase IV on human natural killer cells. Nat. Immun. 13, 270-279.
5. Yaron, A. & Naider, F. (1993) Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28, 31-81.
6. Ulmer, A. J., Mattern, T., Feller, A. C., Heymann, E. & Flad, H.-D. (1990) CD26 antigen is a surface Dipeptidyl peptidase IV (DPPIV) as characterised by monoclonal antibodies clone TII-19-4-7 and 4EL1C1. Scand. J. Immunol. 31, 429-435.
7. Hegen, M., Niedobitek, C., Klein, C. E., Stein, H. & Fleischer, B. (1990) The T cell triggering molecule Tp103 is associated with Dipeptidyl aminopeptidase IV activity. J. Immunol. 144, 2908-2914.
8. Mattern, T., Flad, H.-D., Feller, A. C., Heymann, E. & Ulmer, A. J. (1989) Anti-DPP-IV and anti-Ta1 but not IOT 15 should be clustered in CDw26. In: Leukocyte Typing IV. Knapp, W., Dörken, B., Gilks, W. R., Rieber, E. P., Schmidt, R. E., Stein, H. & Von Dem Borne, A. E. G. K. (Eds.), 416.
9. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F. & Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261, 466-469
10. Morimoto, C., Torimoto, Y., Levinson, G., Rudd, C. E., Schrieber, M., Dang, N. H., Letvin, N. L. & Schlossman, S. F. (1989) 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J. Immunol. 143, 3430-3439.
11. Fleischer, B., Sturm, E., De Vries, J. E. & Spits, H. (1988) Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. J Immunol. 141, 1103-1107.
12. Hegen, M., Camerini, D. & Fleischer, B. (1993) Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Cell. Immunol 146, 249-260.
13. Ansorge, S., Schön, E. & Kunz, D. (1991) Membrane-bound peptidases of lymphocytes: Functional implications. Biomed. Biochem. Acta 50, 799-807.
14. Schön, E., Demuth, U. H., Barth, A. & Ansorge, S. (1984) Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylprolin in T-lymphocytes. Biochem. J. 223, 255-258.
15. Schön, E., Eichmann, E., Grunow, R., Jahn, S., Kiessig, S. T., Volk, H. D. & Ansorge, S. (1986) Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system. Biomed. Biochem. Acta 45, 1523-1528.
16. Dang, N. H., Torimoto, Y., Deusch, K., Schlossman, S. F. & Morimoto, C. (1990) Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol. 144, 4092-4100.
17. Dang, N. H., Torimoto, Y., Sugita, K., Daley, J. F., Show, P., Porado, C., Schlossman, S. F. & Morimoto, C. (1990) Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J. Immunol. 145, 3963.
18. Dang, N. H., Torimoto, Y., Shimamura, K., Tanaka, T., Daley, J. F., Schlossman, S. F. & Morimoto, C. (1991) 1F7 (CD26): A marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol 147, 2825-2832.
19. Schön, E., Born, I., Demuth, H.-U., Faust, J., Neubert, K., Steinmetzer, T., Barth, A. & Ansorge, S. (1991) Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol. Chem. Hoppe Seyler 372, 305-311.
20. Schön, E., Demuth, H.-U., Eichmann, E., Horst, H.-J., Körner, I.-J., Kopp, J., Mattern, T., Neubert, K., Noll, F., Ulmer, J. A., Barth, A. & Ansorge, S. (1989) Dipeptidyl peptidase IV in human T lymphocytes Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand. J. Immunol. 29, 127-132.
21. Schön, E., Jahn, S., Kiessig, S. T., Demuth, H.-U., Neubert, K., Barth, A., von Baehr, R. & Ansorge, S. (1987) The role of dipeptidyl peptidase IV in human T lymphocyte activation. inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur. J. Immunol. 17, 1821-1826.
22. Torimoto, Y., Dang, N. H., Vivier, E., Tanaka, T., Schlossman, S. F. & Morimoto, C. (1991) Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes J. Immunol. 147, 2514-2517.
23. Torimoto, Y., Dang, N. H., Tanaka, T., Prado, C., Schlossman, S. F. & Morimoto, C. (1992) Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol. 29, 183-192.
24. Schön, E., Eichmann, E., Jahn, S., Kopp, J., Volk, H. D. & Ansorge, S. (1988) On the role of dipeptidyl peptidase IV (DP IV) in thew immune system. Relations to the cell cycle and lymphokine production of activated lymphocytes. Biol. Zent. bl. 107, 141-149.
25. Reinhold, D., Bank, U., Bühling, F., Neubert, K., Mattern, T., Ulmer, A. J., Flad, H.-D. & Ansorge, S. (1993) Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against Dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiol. 188, 403-414.
26. Reinhold, D., Bank, U., Bühling, F., Kähne, T., Kunz, D., Faust, J., Neubert, K. & Ansorge, S. (1994) Inhibitors of Dipeptidyl peptidase IV (DP IV, CD26) specifically auppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology 192, 121-136.
27. Fleischer, B. (1987) A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J. Immunol. 138, 1346-1350.
28. Ansorge, S., Bühling, F., Hoffmann, T., Kähne, T., Neubert, K. & Reinhold, D. (1995) DP IV/CD26 on human lymphocytes: Functional roles in cell growth and cytokine regulation. In: Dipeptidyl Peptidase IV (CD26) in metabolism and the immune response. Fleischer, B. (Eds.)R.G. Landes Company, Austin, (10)163-184.
29. Kähne, T., Kröning, H., Thiel, U., Ulmer, A. J., Flad, H.-D. & Ansorge, S. (1996) Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. Cell Immunol. 170, 63-70.
30. Kähne, T. & Ansorge, S. (1994) Non-radioaktive labelling and immunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation. J. Immunol. Methods 168, 209-218
31. lck. Immunol. Lett. 46, 189-193.